scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1013605364 |
P356 | DOI | 10.1023/A:1018487506546 |
P698 | PubMed publication ID | 9328199 |
P2093 | author name string | Volk N | |
Pompe-Kirn V | |||
P433 | issue | 5 | |
P921 | main subject | breast cancer | Q128581 |
P304 | page(s) | 764-770 | |
P577 | publication date | 1997-09-01 | |
P1433 | published in | Cancer Causes & Control | Q325957 |
P1476 | title | Second primary cancers in breast cancer patients in Slovenia | |
P478 | volume | 8 |
Q81483199 | A descriptive study of second primary malignancies associated to breast cancer in a mexican Hispanic population |
Q33733935 | Association between melanocytic nevi and risk of breast diseases: The French E3N prospective cohort |
Q57744383 | BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma |
Q23921281 | Chronic lymphocytic leukemia radiogenicity: a systematic review |
Q51347872 | Collision metastasis of breast and thyroid carcinoma to a single cervical lymph node: report of a case. |
Q47157751 | Development of second primary cancer in Korean breast cancer survivors |
Q48180188 | Do mutations in BRCA1/BRCA2 confer a higher risk of skin cancer? |
Q36671410 | Epidemiologic and molecular risk factors for contralateral breast cancer among young women |
Q34458444 | Epidemiology of breast cancer in older women: implications for future healthcare |
Q48398479 | Estimation of the risk of secondary cancer in the thyroid gland and the breast outside the treated volume in patients undergoing brain, mediastinum and breast radiotherapy |
Q24685936 | Identification of MGB1 as a marker in the differential diagnosis of lung tumors in patients with a history of breast cancer by analysis of publicly available SAGE data |
Q36622589 | Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England |
Q38492314 | Incidence of second primary breast cancer among women with a first primary in Manitoba, Canada |
Q74244606 | Increased risk of second cancers following breast cancer: role of the initial treatment |
Q51129513 | Malignant melanoma and breast carcinoma: a bidirectional correlation. |
Q44627015 | Melanoma and nonmelanoma skin cancer in patients with multiple tumours--evidence for new syndromes in a population-based study. |
Q34977185 | Metachronous double primary cancer after treatment of breast cancer |
Q37193990 | Multiple primary tumours: incidence estimation in the presence of competing risks |
Q33889163 | Pathological confirmation of primary lung cancer following breast cancer |
Q78714688 | Radiation dose, chemotherapy and risk of lung cancer after breast cancer treatment |
Q35863901 | Radiation-induced sarcoma of the breast: a systematic review |
Q38483413 | Risk factors for colorectal cancer following breast cancer |
Q38487369 | Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population-based cohort study |
Q38275366 | Risk of second cancers cancer after a first primary breast cancer: a systematic review and meta-analysis. |
Q38129094 | Risk of second primary cancer after breast cancer treatment. |
Q38426490 | Risk of second primary cancer among women with breast cancer: a population-based study in Granada (Spain). |
Q36494170 | Second malignancies after breast cancer: the impact of different treatment modalities |
Q38494457 | Second primary cancers following breast cancer in the Japanese female population |
Q38294122 | Skin cancer risk in BRCA1/2 mutation carriers |
Q36628995 | The Breast-Thyroid Cancer Link: A Systematic Review and Meta-analysis |
Q79074782 | The Descriptive Epidemiology of Second Primary Breast Cancer |
Q38522413 | The association between breast cancer and thyroid cancer: a meta-analysis |
Q36738264 | The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands. |
Q73940809 | The risk of multiple primary breast and thyroid carcinomas |
Q35066950 | Three Metachronous Cases of HER2-Positive Breast Cancer Accompanied with Thyroid Cancer |
Search more.